Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Female adolescent exposure to cannabinoids causes transgenerational effects on morphine sensitization in female offspring in the absence of in utero exposure.

Vassoler FM, Johnson NL, Byrnes EM.

J Psychopharmacol. 2013 Nov;27(11):1015-22. doi: 10.1177/0269881113503504. Epub 2013 Sep 18.

2.

CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens.

Molaei M, Fatahi Z, Zaringhalam J, Haghparast A.

J Mol Neurosci. 2016 Apr;58(4):446-55. doi: 10.1007/s12031-016-0716-9. Epub 2016 Jan 23.

PMID:
26803309
3.

Cannabinoid exposure in adolescent female rats induces transgenerational effects on morphine conditioned place preference in male offspring.

Byrnes JJ, Johnson NL, Schenk ME, Byrnes EM.

J Psychopharmacol. 2012 Oct;26(10):1348-54. doi: 10.1177/0269881112443745. Epub 2012 Apr 19.

4.

Exposure to opiates in female adolescents alters mu opiate receptor expression and increases the rewarding effects of morphine in future offspring.

Vassoler FM, Wright SJ, Byrnes EM.

Neuropharmacology. 2016 Apr;103:112-21. doi: 10.1016/j.neuropharm.2015.11.026. Epub 2015 Dec 15.

5.

Multigenerational effects of adolescent morphine exposure on dopamine D2 receptor function.

Byrnes JJ, Johnson NL, Carini LM, Byrnes EM.

Psychopharmacology (Berl). 2013 May;227(2):263-72. doi: 10.1007/s00213-012-2960-1. Epub 2013 Jan 13.

6.

Next generation effects of female adolescent morphine exposure: sex-specific alterations in response to acute morphine emerge before puberty.

Vassoler FM, Johnson-Collins NL, Carini LM, Byrnes EM.

Behav Pharmacol. 2014 Apr;25(2):173-81. doi: 10.1097/FBP.0000000000000032.

7.

Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.

Gomes FV, Guimarães FS, Grace AA.

Int J Neuropsychopharmacol. 2014 Dec 13;18(2). pii: pyu018. doi: 10.1093/ijnp/pyu018.

8.

Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons.

Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL.

Biol Psychiatry. 2004 Jul 15;56(2):86-94.

PMID:
15231440
9.

Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist.

Tsou K, Lowitz KA, Hohmann AG, Martin WJ, Hathaway CB, Bereiter DA, Walker JM.

Neuroscience. 1996 Feb;70(3):791-8.

PMID:
10627219
10.

The effect of chronic opioid vs. cannabinoid exposure on the expression of tolerance to morphine- or WIN-55,212-2-induced analgesia and hypothermia in the guinea pig.

Maguma H, Taylor DA.

Eur J Pharmacol. 2011 Jun 25;660(2-3):334-40. doi: 10.1016/j.ejphar.2011.04.010. Epub 2011 Apr 15.

PMID:
21514292
11.

Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference.

Karimi S, Azizi P, Shamsizadeh A, Haghparast A.

Behav Brain Res. 2013 Jun 15;247:125-31. doi: 10.1016/j.bbr.2013.03.022. Epub 2013 Mar 21.

PMID:
23523958
13.
14.

Characteristics of tolerance in the guinea pig ileum produced by chronic in vivo exposure to opioid versus cannabinoid agonists.

Maguma H, Thayne K, Taylor DA.

Biochem Pharmacol. 2010 Aug 15;80(4):522-32. doi: 10.1016/j.bcp.2010.05.005. Epub 2010 May 15.

PMID:
20478271
15.

Dual role of PPAR-γ in induction and expression of behavioral sensitization to cannabinoid receptor agonist WIN55,212-2.

Enayatfard L, Rostami F, Nasoohi S, Oryan S, Ahmadiani A, Dargahi L.

Neuromolecular Med. 2013 Sep;15(3):523-35. doi: 10.1007/s12017-013-8238-x. Epub 2013 Jun 21.

PMID:
23794089
16.

Adolescent experience affects postnatal ultrasonic vocalizations and gene expression in future offspring.

Bodi CM, Vassoler FM, Byrnes EM.

Dev Psychobiol. 2016 Sep;58(6):714-23. doi: 10.1002/dev.21411. Epub 2016 Mar 21.

17.
18.

Interactions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.

Maguire DR, Yang W, France CP.

J Pharmacol Exp Ther. 2013 Jun;345(3):354-62. doi: 10.1124/jpet.113.204099. Epub 2013 Mar 27. Erratum in: J Pharmacol Exp Ther. 2014 Mar;348(3):490-1. Dosage error in article text.

19.

Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure.

Polissidis A, Chouliara O, Galanopoulos A, Marselos M, Papadopoulou-Daifoti Z, Antoniou K.

Life Sci. 2009 Jul 31;85(5-6):248-54. doi: 10.1016/j.lfs.2009.05.015. Epub 2009 Jun 7.

PMID:
19508876
20.

Behavioral sensitization to heroin by cannabinoid pretreatment in the rat.

Pontieri FE, Monnazzi P, Scontrini A, Buttarelli FR, Patacchioli FR.

Eur J Pharmacol. 2001 Jun 15;421(3):R1-3.

PMID:
11516439

Supplemental Content

Support Center